Association of plasma F2-isoprostanes and isofurans concentrations with erythropoiesis-stimulating agent resistance in maintenance hemodialysis patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Association of plasma F2-isoprostanes and isofurans concentrations with erythropoiesis-stimulating agent resistance in maintenance hemodialysis patients ; volume:16 ; number:1 ; day:5 ; month:6 ; year:2015 ; pages:1-12 ; date:12.2015
BMC nephrology ; 16, Heft 1 (5.6.2015), 1-12, 12.2015
- Creator
-
Rivara, Matthew B.
- Contributor
-
Ikizler, T. Alp
Ellis, Charles D.
Mehrotra, Rajnish
Himmelfarb, Jonathan
SpringerLink (Online service)
- DOI
-
10.1186/s12882-015-0074-9
- URN
-
urn:nbn:de:1111-201611058802
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:04 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rivara, Matthew B.
- Ikizler, T. Alp
- Ellis, Charles D.
- Mehrotra, Rajnish
- Himmelfarb, Jonathan
- SpringerLink (Online service)
Other Objects (12)
Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients
Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient
Role of circulating endothelial progenitors in responsiveness to erythropoiesis-stimulating agents in hemodialysis patients
The effect of altitude on erythropoiesis-stimulating agent dose, hemoglobin level, and mortality in hemodialysis patients
Serum trace metal association with response to erythropoiesis stimulating agents in incident and prevalent hemodialysis patients
Erythropoiesis stimulating agents and reno-protection: a meta-analysis
Lessons from clinical trials with erythropoiesis-stimulating agents (ESAs)
Tips for erythropoiesis-stimulating agent treatment of renal anemia
Association between Dipeptidyl Peptidase-4 Inhibitor Prescription and Erythropoiesis-Stimulating Agent Hyporesponsiveness in Hemodialysis Patients with Diabetes Mellitus
Different effects of granulocyte colony-stimulating factor and erythropoietin on erythropoiesis
Proton Pump Inhibitors and Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Hemodialysis Patients: Results from the Japan Dialysis Outcomes and Practice Patterns Study
Association between high-dose erythropoiesis-stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors
Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients
Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient
Role of circulating endothelial progenitors in responsiveness to erythropoiesis-stimulating agents in hemodialysis patients
The effect of altitude on erythropoiesis-stimulating agent dose, hemoglobin level, and mortality in hemodialysis patients
Serum trace metal association with response to erythropoiesis stimulating agents in incident and prevalent hemodialysis patients
Erythropoiesis stimulating agents and reno-protection: a meta-analysis
Lessons from clinical trials with erythropoiesis-stimulating agents (ESAs)
Tips for erythropoiesis-stimulating agent treatment of renal anemia
Association between Dipeptidyl Peptidase-4 Inhibitor Prescription and Erythropoiesis-Stimulating Agent Hyporesponsiveness in Hemodialysis Patients with Diabetes Mellitus
Different effects of granulocyte colony-stimulating factor and erythropoietin on erythropoiesis
Proton Pump Inhibitors and Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Hemodialysis Patients: Results from the Japan Dialysis Outcomes and Practice Patterns Study
Association between high-dose erythropoiesis-stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors
Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients
Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient
Role of circulating endothelial progenitors in responsiveness to erythropoiesis-stimulating agents in hemodialysis patients
The effect of altitude on erythropoiesis-stimulating agent dose, hemoglobin level, and mortality in hemodialysis patients
Serum trace metal association with response to erythropoiesis stimulating agents in incident and prevalent hemodialysis patients
Erythropoiesis stimulating agents and reno-protection: a meta-analysis
Lessons from clinical trials with erythropoiesis-stimulating agents (ESAs)
Tips for erythropoiesis-stimulating agent treatment of renal anemia
Association between Dipeptidyl Peptidase-4 Inhibitor Prescription and Erythropoiesis-Stimulating Agent Hyporesponsiveness in Hemodialysis Patients with Diabetes Mellitus
Different effects of granulocyte colony-stimulating factor and erythropoietin on erythropoiesis
Proton Pump Inhibitors and Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Hemodialysis Patients: Results from the Japan Dialysis Outcomes and Practice Patterns Study